Cryo-Cell International
CCEL
14 hedge funds and large institutions have $4.33M invested in Cryo-Cell International in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
3.72% more ownership
Funds ownership: 8.3% → 12.02% (+3.7%)
2% more capital invested
Capital invested by funds: $4.25M → $4.33M (+$84.6K)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
+$1.96M |
| 2 |
Cerity Partners
New York
|
+$93.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.94K |
| 5 |
BlackRock
New York
|
+$1.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$401K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.77K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$369 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HLA
1
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
| $1.73M | +$1.96M | +409,734 | New |
|
|
ICM
2
ISZO Capital Management
New York
| $825K | -$401K | -83,842 | -30% |
|
|
SA
3
SFI Advisors
Montclair,
New Jersey
| $699K | – | – | – |
|
|
MPWT
4
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $525K | – | – | – |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $306K | +$369 | +77 | +0.1% |
|
|
6
Cerity Partners
New York
| $82.8K | +$93.7K | +19,563 | New |
|
|
7
Geode Capital Management
Boston,
Massachusetts
| $80K | -$369 | -77 | -0.4% |
|
|
8
BlackRock
New York
| $51K | +$1.28K | +268 | +2% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $9K | +$3.94K | +822 | +64% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $8K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $7.29K | +$7.6K | +1,587 | +1,158% |
|
12
Morgan Stanley
New York
| $3.38K | – | – | – |
|
13
Wells Fargo
San Francisco,
California
| $102 | +$5 | +1 | +4% |
|
|
14
Bank of America
Charlotte,
North Carolina
| $17 | -$4.77K | -996 | -100% |
|
CCEL Hedge Fund Activity: Q4 2022 in Review
14 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q4 2022, worth a combined $4.33M — up 2% from $4.25M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CCEL positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Hamilton Lane Advisors, opening a new position worth an estimated $1.96M. The largest seller was ISZO Capital Management, cutting an estimated $401K.
- 14 institutional investors held Cryo-Cell International (CCEL) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $4.33M of Cryo-Cell International stock for Q4 2022, up 2% quarter-over-quarter.
- 2 funds opened new Cryo-Cell International positions in Q4 2022 and 1 closed out, a net change of +1 holder.
- The largest Cryo-Cell International buyer in Q4 2022 was Hamilton Lane Advisors, an estimated $1.96M added.
- The largest Cryo-Cell International seller in Q4 2022 was ISZO Capital Management, an estimated $401K sold.
Based on aggregated 13F filings for Q4 2022.